Home > Press > Nanophase Cosponsors Sixth Annual NanoBusiness Alliance Conference
Abstract:
Nanophase CEO to Present at NanoBusiness Investors Forum
Nanophase Technologies (Nasdaq: NANX), a technology leader in nanomaterials and
advanced nanoengineered products, announced plans to cosponsor and present
at the NanoBusiness Alliance 2007 Conference, April 15-17 at the New York
Marriott Marquis. As nanotechnology's foremost business conference,
NanoBusiness 2007 is intended for major stakeholders in the business of
nanotechnology and gathers important technologists, government and
investment leaders, nanotechnology business leaders, and investors for
three intensive days of seminars, presentations, and panel discussions.
NanoBusiness 2007 brings world-class nanotechnology companies to Wall
Street to highlight nanotech innovations that are expected to drive
shareholder value creation over the next decade. Joseph Cross, Nanophase's
president and CEO, will participate in a panel discussion on Monday, April
16, to discuss "Advanced Materials: Scaling the Business to a Size that
Matters" and present the Company's portfolio of nanomaterials technologies,
revenue growth strategies, and vision for the future to an investor forum
on Tuesday, April 17. Along with other nanotechnology executives, Mr. Cross
has also been invited to participate in NASDAQ's closing bell ceremonies on
Tuesday, April 17.
"NanoBusiness 2007 is a principal gathering of international
nanotechnology sectors and companies focused on the growth and rapid
commercialization of nanotechnologies," stated Mr. Cross. "This is a major
gathering of leading nanotechnology companies who are successfully
commercializing nanotech innovations across multiple sectors, showcasing
the 'here and now' as well as a vision of the future. Focusing on issues
and conditions that are expected to drive increased global implementation,
discussions range from technology to markets to corporate environmental and
workplace responsibility. It is an important business conference for
growing nanotechnologies that are undergoing an increasing rate of global
adoption, such as Nanophase."
Sean Murdock, Executive Director of the NanoBusiness Alliance stated,
"We are excited to have Joe Cross speaking about scaling the nanomaterials
business. Nanophase has been a world leader in commercializing
nanomaterials and has developed a network of partnerships with leading
incumbents that will allow the company to rapidly bring new innovations to
the marketplace."
####
About Nanophase Technologies Corporation
Nanophase Technologies Corporation (NANX), http://www.nanophase.com ,
is a leader in nanomaterials technologies and provides nanoengineered
solutions for multiple industrial product applications. Using a platform of
patented and proprietary integrated nanomaterial technologies, the Company
creates products with unique performance attributes from two ISO 9001:2000
and ISO 14001 facilities. Nanophase delivers commercial quantity and
quality nanoparticles, coated nanoparticles, and nanoparticle dispersions
in a variety of media. The Company owns or licenses 18 United States and 48
foreign patents and patent applications. Information about Nanophase may be
found in the Company's public filings or on its website.
The NanoBusiness Alliance is the industry association for the emerging
nanotech industry. Through its extensive network of leading startups,
Fortune 500 companies, research institutions, non-governmental
organizations and public-private partnerships, the Alliance influences
nanotechnology policy and helps accelerate commercialization of
nanotechnology innovations. The NanoBusiness Alliance has offices in New
York, Chicago, Connecticut and Washington, DC. For more information, visit
http://www.nanobusiness.org .
This press release contains words such as "expects", "shall", "will",
"believes" and similar expressions that are intended to identify forward-
looking statements within the meaning of the Safe Harbor Provisions of the
Private Securities Litigation Reform Act of 1995. Such statements in this
announcement are made based on the Company's current beliefs, known events
and circumstances at the time of publication, and as such, are subject in
the future to unforeseen risks and uncertainties that could cause the
Company's results of operations, performance and achievements to differ
materially from current expectations expressed in, or implied by, these
forward-looking statements. These risk and uncertainties include the
following: a decision by a customer to cancel a purchase order or supply
agreement in light of the Company's dependence on a limited number of key
customers; uncertain demand for, and acceptance of, the Company's
nanocrystalline materials; the Company's manufacturing capacity and product
mix flexibility in light of customer demand; the Company's limited
marketing experience; changes in development and distribution
relationships; the impact of competitive products and technologies; the
Company's dependence on patents and protection of proprietary information;
the resolution of litigation in which the Company may become involved; and
other risks described in the Company's Form 10K filed March 14, 2007, and
other filings with the Securities and Exchange Commission. In addition, the
Company's forward-looking statements could be affected by general industry
and market conditions and growth rates. Except as required by federal
securities laws, the Company undertakes no obligation to update or revise
these forward-looking statements to reflect new events, uncertainties or
other contingencies.
For more information, please click here
Copyright © PR Newswire Association LLC.
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Events/Classes
A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024
Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||